Bakker Juliet Tammenoms - Net Worth and Insider Trading

Bakker Juliet Tammenoms Net Worth

The estimated net worth of Bakker Juliet Tammenoms is at least $414 Million dollars as of 2024-11-05. Bakker Juliet Tammenoms is the 10% Owner of Aimmune Therapeutics Inc and owns about 6,029,785 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $208 Million. Bakker Juliet Tammenoms is the Director of Axonics Inc and owns about 1,959,859 shares of Axonics Inc (AXNX) stock worth over $138 Million. Bakker Juliet Tammenoms is also the Director of CeriBell Inc and owns about 2,481,728 shares of CeriBell Inc (CBLL) stock worth over $66 Million. Besides these, Bakker Juliet Tammenoms also holds RxSight Inc (RXST) , Eargo Inc (EAR) . Details can be seen in Bakker Juliet Tammenoms's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bakker Juliet Tammenoms has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bakker Juliet Tammenoms

To

Bakker Juliet Tammenoms Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bakker Juliet Tammenoms owns 20 companies in total, including Eargo Inc (EAR) , Axonics Inc (AXNX) , and Molecular Templates Inc (MTEM) among others .

Click here to see the complete history of Bakker Juliet Tammenoms’s form 4 insider trades.

Insider Ownership Summary of Bakker Juliet Tammenoms

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 director & 10 percent owner
AXNX Axonics Inc 2020-09-18 director & 10 percent owner
MTEM Molecular Templates Inc 2019-11-25 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2019-11-08 10 percent owner
LIMIT LIMIT 2020-06-11 10 percent owner
LIMIT LIMIT 2019-11-07 director
LIMIT LIMIT 2019-11-22 10 percent owner
LIMIT LIMIT 2018-06-27 10 percent owner
LIMIT LIMIT 2018-06-20 10 percent owner
LIMIT LIMIT 2018-02-22 10 percent owner
LIMIT LIMIT 2015-05-06 10 percent owner
LIMIT LIMIT 2017-07-19 10 percent owner
LIMIT LIMIT 2008-03-25 director & 10 percent owner
LIMIT LIMIT 2014-10-07 10 percent owner
LIMIT LIMIT 2024-05-17 director
LIMIT LIMIT 2021-07-19 10 percent owner
LIMIT LIMIT 2021-05-06 10 percent owner
LIMIT LIMIT 2022-02-10 10 percent owner
LIMIT LIMIT 2023-11-02 10 percent owner

Bakker Juliet Tammenoms Latest Holdings Summary

Bakker Juliet Tammenoms currently owns a total of 5 stocks. Among these stocks, Bakker Juliet Tammenoms owns 6,029,785 shares of Aimmune Therapeutics Inc (AIMT) as of February 22, 2018, with a value of $208 Million and a weighting of 50.18%. Bakker Juliet Tammenoms owns 1,959,859 shares of Axonics Inc (AXNX) as of September 18, 2020, with a value of $138 Million and a weighting of 33.29%. Bakker Juliet Tammenoms also owns 2,481,728 shares of CeriBell Inc (CBLL) as of October 15, 2024, with a value of $66 Million and a weighting of 15.96%. The other 2 stocks RxSight Inc (RXST) , Eargo Inc (EAR) have a combined weighting of 0.57% among all his current holdings.

Latest Holdings of Bakker Juliet Tammenoms

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AIMT Aimmune Therapeutics Inc 2018-02-22 6,029,785 34.49 207,967,285
AXNX Axonics Inc 2020-09-18 1,959,859 70.40 137,964,274
CBLL CeriBell Inc 2024-10-15 2,481,728 26.65 66,138,051
RXST RxSight Inc 2024-05-17 36,388 51.53 1,874,892
EAR Eargo Inc 2020-10-20 195,935 2.57 503,553

Holding Weightings of Bakker Juliet Tammenoms


Bakker Juliet Tammenoms Form 4 Trading Tracker

According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 9,375 shares on February 22, 2018, which cost Bakker Juliet Tammenoms around $300,000.

According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 2 transactions in Axonics Inc (AXNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Axonics Inc is the sale of 9,167 shares on September 18, 2020, which brought Bakker Juliet Tammenoms around $391,156.

According to the SEC Form 4 filings, Bakker Juliet Tammenoms has made a total of 1 transactions in CeriBell Inc (CBLL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CeriBell Inc is the acquisition of 237,234 shares on October 15, 2024, which cost Bakker Juliet Tammenoms around $4 Million.

More details on Bakker Juliet Tammenoms's insider transactions can be found in the Insider Trading History of Bakker Juliet Tammenoms table.

Insider Trading History of Bakker Juliet Tammenoms

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bakker Juliet Tammenoms Trading Performance

GuruFocus tracks the stock performance after each of Bakker Juliet Tammenoms's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bakker Juliet Tammenoms is 16.18%. GuruFocus also compares Bakker Juliet Tammenoms's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bakker Juliet Tammenoms within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bakker Juliet Tammenoms's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bakker Juliet Tammenoms

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.87 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.67 LIMIT LIMIT LIMIT LIMIT LIMIT

Bakker Juliet Tammenoms Ownership Network

Ownership Network List of Bakker Juliet Tammenoms

No Data

Ownership Network Relation of Bakker Juliet Tammenoms

Insider Network Chart

Bakker Juliet Tammenoms Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Bakker Juliet Tammenoms is the director & 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Bakker Juliet Tammenoms made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Bakker Juliet Tammenoms Mailing Address

Above is the net worth, insider trading, and ownership report for Bakker Juliet Tammenoms. You might contact Bakker Juliet Tammenoms via mailing address: Longitude Capital Management Co., Llc, 800 El Camino Real, Suite 220, Menlo Park Ca 94025.